BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker Corporation (NYSE:SYK) on Friday, setting a price target of $275, which is approximately 7.15% above the present share price of $256.66.
Zimmerman expects Stryker Corporation to post earnings per share (EPS) of $0.80 for the second quarter of 2021.
The current consensus among 20 TipRanks analysts is for a Moderate Buy rating of shares in Stryker, with an average price target of $279.11.
The analysts price targets range from a high of $303 to a low of $248.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $3.95 billion and a net profit of $465 million. The company's market cap is $96.7 billion.
According to TipRanks.com, BTIG analyst Ryan Zimmerman is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 31.1% and a 62.26% success rate.
Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.